Meeder Asset Management’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-88
| Closed | -$1.3K | – | 914 |
|
|
2024
Q1 | $1.3K | Buy |
+88
| New | +$1.3K | ﹤0.01% | 724 |
|
|
2022
Q3 | – | Sell |
-14
| Closed | – | – | 2242 |
|
|
2022
Q2 | $0 | Sell |
14
-1,063
| -99% | – | ﹤0.01% | 2303 |
|
|
2022
Q1 | $18K | Buy |
+1,077
| New | +$18K | ﹤0.01% | 1326 |
|
|
2021
Q2 | – | Sell |
-13,881
| Closed | -$439K | – | 2581 |
|
|
2021
Q1 | $439K | Buy |
+13,881
| New | +$439K | 0.02% | 525 |
|
|
2020
Q4 | – | Sell |
-6,288
| Closed | -$207K | – | 2040 |
|
|
2020
Q3 | $207K | Sell |
6,288
-1,741
| -22% | -$57.3K | 0.01% | 604 |
|
|
2020
Q2 | $220K | Buy |
8,029
+1,880
| +31% | +$51.5K | 0.01% | 578 |
|
|
2020
Q1 | $185K | Sell |
6,149
-1,885
| -23% | -$56.7K | 0.01% | 589 |
|
|
2019
Q4 | $223K | Buy |
8,034
+1,678
| +26% | +$46.6K | 0.01% | 572 |
|
|
2019
Q3 | $116K | Buy |
6,356
+5,207
| +453% | +$95K | 0.01% | 754 |
|
|
2019
Q2 | $29K | Buy |
1,149
+198
| +21% | +$5K | ﹤0.01% | 1115 |
|
|
2019
Q1 | $9K | Sell |
951
-99
| -9% | -$937 | ﹤0.01% | 1269 |
|
|
2018
Q4 | $9K | Buy |
1,050
+706
| +205% | +$6.05K | ﹤0.01% | 1275 |
|
|
2018
Q3 | $3K | Sell |
344
-1,068
| -76% | -$9.31K | ﹤0.01% | 1407 |
|
|
2018
Q2 | $18.1K | Sell |
1,412
-208
| -13% | -$2.66K | ﹤0.01% | 987 |
|
|
2018
Q1 | $28K | Buy |
1,620
+513
| +46% | +$8.87K | ﹤0.01% | 802 |
|
|
2017
Q4 | $9K | Buy |
1,107
+871
| +369% | +$7.08K | ﹤0.01% | 1151 |
|
|
2017
Q3 | $2K | Sell |
236
-1,489
| -86% | -$12.6K | ﹤0.01% | 1457 |
|
|
2017
Q2 | $13K | Buy |
1,725
+1,235
| +252% | +$9.31K | ﹤0.01% | 928 |
|
|
2017
Q1 | $4K | Buy |
+490
| New | +$4K | ﹤0.01% | 1163 |
|